HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coovadia, H M Articles by Brain, P Search for Related Content PubMed PubMed Citation Articles by Coovadia, H M Articles by Brain, P

Immunological events in acute measles influencing outcome.

77% of 30 children with measles who had severe lymphopenia (less than 2000/mm3; less than 2.0 x 10(9)/1) within 2 days of appearance of rash (group A) subsequently died or progressed to chronic chest disease. This was significantly worse than the outcome in 30 children with measles who had lymphocyte counts more than 2000/mm3 (more than 2.0 x 10(9)/1) (group B) of whom 67% recovered. In group A children the persistence of severe lymphopenia (caused by a reduction in T- and B-cells) for at least 15 days after onset of rash, remained a good predictive index of morbidity and mortality. Reversal of immunoparesis in group A was slower and incomplete 42 days from appearance of the rash in those who subsequently died or developed chronic chest disease compared with those who recovered. All patients who died failed to produce adequate measles antibodies. The therapeutic implications and immunopathological significance of these findings for chronic complications after acute measles are discussed.

This article has been cited by other articles:

				M. Colomar, I. Puga, M. Lopez, M. Massot, J. I. Jorquera, M. Reina, S. Vilaro, and E. Espel Neutralization of Measles Virus Infectivity and Antibody-Dependent Cell-Mediated Cytotoxicity Activity against an Epstein-Barr Virus-Infected Cell Line by Intravenous Administration of Immunoglobulin G Clin. Vaccine Immunol., September 1, 2003; 10(5): 751 - 756. [Abstract] [Full Text] [PDF]

				J. J. Ryon, W. J. Moss, M. Monze, and D. E. Griffin Functional and Phenotypic Changes in Circulating Lymphocytes from Hospitalized Zambian Children with Measles Clin. Vaccine Immunol., September 1, 2002; 9(5): 994 - 1003. [Abstract] [Full Text] [PDF]

				S. N. Manié, S. Debreyne, S. Vincent, and D. Gerlier Measles Virus Structural Components Are Enriched into Lipid Raft Microdomains: a Potential Cellular Location for Virus Assembly J. Virol., January 1, 2000; 74(1): 305 - 311. [Abstract] [Full Text]

				I. Fugier-Vivier, C. Servet-Delprat, P. Rivailler, M.-C. Rissoan, Y.-J. Liu, and C. Rabourdin-Combe Measles Virus Suppresses Cell-mediated Immunity by Interfering with the Survival and Functions of Dendritic and T Cells J. Exp. Med., September 15, 1997; 186(6): 813 - 823. [Abstract] [Full Text] [PDF]